ATRX and central nervous system cancer: The ESTIMATE algorithm was used to calculate immune and stromal scores for ATRX-mutation-type (ATRX-mt) and ATRX-wt glioma patients from TCGA, and the median scores were used to divide patients into high- and low-scoring groups.